Validation of a predictive model for potential response to neoadjuvant endocrine therapy (NET) in postmenopausal women with clinical stage II or III estrogen receptor positive (ER+) and HER2 negative (HER2-) breast cancer (BC): An ALTERNATE trial analysis (Alliance A011106) Meeting Abstract


Authors: Ellis, M. J.; Suman, V.; Leitch, A. M.; Sanati, S.; Vij, K.; Unzeitig, G. W.; Hoog, J.; Watson, M.; Hahn, O.; Guenther, J.; Caudle, A.; Crouch, E.; Maluf, H.; Dowsett, M.; Tiersten, A.; Mita, M.; Razaq, W.; Hieken, T. J.; Wang, Y.; Dockter, T.; Zujewski, J. A.; Weiss, A.; Hudis, C.; Winer, E. P.; Hunt, K.; Partridge, A. H.; Ma, C. X.; Carey, L. A.
Abstract Title: Validation of a predictive model for potential response to neoadjuvant endocrine therapy (NET) in postmenopausal women with clinical stage II or III estrogen receptor positive (ER+) and HER2 negative (HER2-) breast cancer (BC): An ALTERNATE trial analysis (Alliance A011106)
Meeting Title: 43rd Annual San Antonio Breast Cancer Symposium (2020 SABCS)
Journal Title: Cancer Research
Volume: 81
Issue: 4 Suppl.
Meeting Dates: 2020 Dec 8-11
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2021-02-01
Language: English
ACCESSION: WOS:000618737700189
PROVIDER: wos
DOI: 10.1158/1538-7445.SABCS20-PD2-10
Notes: Meeting Abstract: PD2-10 -- This symposium was held virtually due to COVID-19 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Clifford Hudis
    905 Hudis